Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANTEOTECH LTD Board/Management Information 2013

Nov 6, 2013

64304_rns_2013-11-06_30e85d8a-8945-4f72-8527-70233306fc58.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [207 x 115] intentionally omitted <==

07 November 2013

Company Announcements Office Australian Stock Exchange Level 6

20 Bridge Street Sydney NSW 2000

UPDATED CEO EMPLOYEMENT CONTRACT

Anteo advises that the Company and Dr Geoff Cumming have agreed the terms of an updated 3 year Employment Agreement. Dr Geoff Cumming’s remuneration package comprises the following:

  • A salary package of $400,000 per annum, plus statutory superannuation, to be reviewed annually;

  • Annual leave of 4 weeks;

  • A short term incentive component consisting of a cash bonus based on achievement of revenue targets as set out by the Company; and

  • As approved at the recent 2013 AGM, a long term incentive component consisting of an option package of 6,000,000 unlisted options with an exercise price of $.12 cents, an expiry date of 4 years from date of issue, and vesting conditions. The long term option package will be reviewed annually to reflect current market conditions.

For More Information Contact:

Dr Geoff Cumming, CEO Anteo Diagnostics Limited Tel: +61 7 3219 0085

Sam Sloane Six Degrees Investor Relations Tel: +61 2 9230 0661

Anteo Diagnostics Limited ABN 78 090 487 273 Unit 4, 26 Brandl Street, Eight Mile Plains Qld 4113 Phone 07 3219 0085 Fax 07 3219 0553 Email [email protected] Web www.anteodx.com